Forkhead box protein O pathway (FOXO pathway)

The Forkhead box protein O (FOXO) pathway is a critical signaling network centered on a family of four transcription factors—FOXO1, FOXO3, FOXO4, and FOXO6—that integrate environmental cues to regulate cellular homeostasis. These proteins act as downstream effectors of the PI3K/AKT signaling cascade, which negatively regulates FOXO activity through phosphorylation, resulting in their nuclear exclusion and proteasomal degradation. When active in the nucleus, FOXO proteins modulate the expression of genes involved in cell cycle arrest, DNA repair, and apoptosis, effectively serving as context-dependent tumor suppressors. Beyond oncology, the pathway is a master regulator of metabolic processes, such as hepatic gluconeogenesis, and plays a significant role in aging and longevity by enhancing cellular resistance to oxidative stress. Therapeutic targeting of the FOXO pathway includes the development of direct inhibitors for metabolic diseases and the use of indirect modulators like PI3K and AKT inhibitors in cancer therapy to restore FOXO-mediated pro-apoptotic signals.

Other names

Forkhead box O transcription factorsFOXO transcription factorsForkhead box O familyForkhead box class ODAF-16 signaling pathway

The pathway is primarily modulated by the PI3K/AKT axis; AKT-mediated phosphorylation of FOXO proteins leads to their cytoplasmic sequestration and inactivation, while inhibitors of PI3K, AKT, or EGFR promote FOXO nuclear translocation to drive the transcription of genes for apoptosis and cell cycle arrest. Direct small-molecule inhibitors (e.g., AS1842856) can also bind to FOXO1 to suppress its transcriptional activity in metabolic contexts.